Anika Therapeutics (ANIK) Enterprise Value (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Enterprise Value of -$38.4 million for Q2 2026, up 50.19% year-over-year from -$25.6 million in Q2 2025, and up 42.49% quarter-over-quarter from -$66.8 million in Q1 2026.
Anika Therapeutics (ANIK) Enterprise Value (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Enterprise Value for 17 consecutive years, with -$38.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value rose 50.19% year-over-year to -$38.4 million; the TTM figure through Jun 2026 stood at -$38.4 million (up 50.19% YoY), while the FY2025 annual figure was -$81.2 million, down 2.46% from the prior year.
- Enterprise Value advanced to -$38.4 million in Q2 2026 per ANIK's latest filing, from -$66.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$38.4 million in Q2 2026 and bottomed at -$123.6 million in Q2 2022.
- Historically, Enterprise Value has averaged -$93.6 million across 5 years, with a median of -$95.8 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value sank 34.04% — and 2026, when it jumped 50.19%.
- Anika Therapeutics' Enterprise Value stood at -$121.0 million in 2022, then climbed by 21.38% to -$95.1 million in 2023, then grew by 16.7% to -$79.2 million in 2024, then fell by 2.46% to -$81.2 million in 2025, then soared by 52.68% to -$38.4 million in 2026.
- Business Quant data shows ANIK's Enterprise Value at -$38.4 million in Q2 2026, -$66.8 million in Q1 2026, and -$81.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | -38.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.41 Mn |
| Mar 31, 2026 | -66.79 Mn |
| Dec 31, 2025 | -81.17 Mn |
| Sep 30, 2025 | -80.18 Mn |
| Jun 30, 2025 | -77.12 Mn |
| Mar 31, 2025 | -75.36 Mn |
| Dec 31, 2024 | -79.22 Mn |
| Sep 30, 2024 | -90.73 Mn |
| Jun 30, 2024 | -96.60 Mn |
| Mar 31, 2024 | -100.71 Mn |
| Dec 31, 2023 | -95.10 Mn |
| Sep 30, 2023 | -105.33 Mn |
| Jun 30, 2023 | -101.81 Mn |
| Mar 31, 2023 | -110.37 Mn |
| Dec 31, 2022 | -120.95 Mn |
| Sep 30, 2022 | -121.95 Mn |
| Jun 30, 2022 | -123.56 Mn |
| Mar 31, 2022 | -119.64 Mn |
| Dec 31, 2021 | -124.23 Mn |
| Sep 30, 2021 | -90.98 Mn |